2012 Publications

NoTitleAuthorsYear
1‘Worse than HIV’ or ‘not as serious as other diseases’? Conceptualization of cervical cancer among newly screened women in ZambiaWhite HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, Moneyham L, Grimley DM, Chamot E2012
2A Model of Tuberculosis Screening for Pregnant Women in Resource-Limited Settings Using Xpert MTB/RIFTurnbull ER, Kancheya NG, Harris JB, Topp SM, Henostroza G, Reid SE2012
3Acyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populationsLu Y, Celum C, Wald A, Baeten JM, Cowan F, Delany-Moretlwe S, Reid SE, Hughes JP, Wilcox E, Corey L, Hendrix CW2012
4An evaluation of the role of peer educators in HIV care and treatment clinics in Lusaka, ZambiaBorn L, Wamulume C, Neroda K, Quiterio N, Giganti M, Morris M, Baird S, Sinkamba M, Topp S, Reid SE2012
5Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essentialSahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH2012
6Clinic-Based Food Assistance is Associated with Increased Medication Adherence among HIV-Infected Adults on Long-Term Antiretroviral Therapy in ZambiaTirivayi N, Koethe JR, Groot W2012
7Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trialBaeten JM, Reid SE, Delany-Moretlwe S, Hughes JP, Wang RS, Wilcox E, Limbada M, Akpomiemie G, Corey L, Wald A, Celum C2012
8Does provider-initiated counselling and testing (PITC) strengthen early diagnosis and treatment initiation? Results from an analysis of an urban cohort of HIV-positive patients in Lusaka, ZambiaTopp SM, Li MS, Chipukuma JM, Chiko MM, Matongo E, Bolton-Moore C, Reid SE2012
9Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort studyStringer JS, Mwango AJ, Giganti MJ, Mulenga L, Levy JW, Stringer EM, Mulenga P, Saag MS, Musonda P, Williams FB, Reid SE, Chi BH2012
10Exploring a Road Map to Counter Misconceptions About the Cervicovaginal Microbiome and DiseaseMacklaim JM, Cohen CR, Donders G, Gloor GB, Hill JE, Parham GP, Ravel J, Spear G, van de Wijgert J, Reid G2012
11Health facility characteristics and their relationship to coverage of PMTCT of HIV services across four African countries: the PEARL studyEkouevi DK, Stringer E, Coetzee D, Tih P, Creek T, Stinson K, Westfall AO, Welty T, Chintu N, Chi BH, Wilfert C, Shaffer N, Stringer J, Dabis F2012
12HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 studyPorter KA, Cole SR, Eron JJ Jr, Zheng Y, Hughes MD, Lockman S, Poole C, Skinner-Adams TS, Hosseinipour M, Shaffer D, D'Amico R, Sawe FK, Siika A, Stringer E, Currier JS, Chipato T, Salata R, McCarthy JS, Meshnick SR: AIDS Clinical Trials Group A5208 study2012
13Impact of organizational factors on adherence to laboratory testing protocols in adult HIV care in Lusaka, ZambiaDeo S, Topp SM, Westfall AO, Chiko MM, Wamulume CS, Morris M, Reid S2012
14Integrating HIV treatment with primary care outpatient services: opportunities and challenges from a scaled-up model in ZambiaTopp SM, Chipukuma JM, Chiko MM, Matongo E, Bolton-Moore C, Reid SE2012
15Introduction of rapid syphilis testing within prevention of mother-to-child transmission of HIV programs in Uganda and Zambia: a field acceptability and feasibility studyStrasser S, Bitarakwate E, Gill M, Hoffman HJ, Musana O, Phiri A, Shelley KD, Sripipatana T, Ncube AT, Chintu N2012
16Modeling the impact of integrating HIV and outpatient health services on patient waiting times in an urban health clinic in ZambiaDeo S, Topp SM, Garcia A, Soldner M, Yagci Sokat K, Chipukuma J, Wamulume CS, Reid SE, Swann J2012
17Motivations and experiences of women who accessed “see and treat” cervical cancer prevention services in ZambiaWhite HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, Kapambwe S, Moneyham L, Kempf MC, Chamot E2012
18Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trialLockman S, Hughes M, Sawe F, Zheng Y, McIntyre J, Chipato T, Asmelash A, Rassool M, Kimaiyo S, Shaffer D, Hosseinipour M, Mohapi L, Ssali F, Chibowa M, Amod F, Halvas E, Hogg E, Alston-Smith B, Smith L, Schooley R, Mellors J, Currier J; OCTANE (Optimal Combination Therapy After Nevirapine Exposure) ACTG A5208/OCTANE Study Team2012
19Point-of-care tests to strengthen health systems and save newborn lives: the case of syphilisMabey DC, Sollis KA, Kelly HA, Benzaken AS, Bitarakwate E, Changalucha J, Chen XS, Yin YP, Garcia PJ, Strasser S, Chintu N, Pang T, Terris-Prestholt F, Sweeney S, Peeling RW2012
20Progress, challenges, and new opportunities for the prevention of mother-to-child transmission of HIV under the US President’s Emergency Plan for AIDS ReliefChi BH, Adler MR, Bolu O, Mbori-Ngacha D, Ekouevi DK, Gieselman A, Chipato T, Luo C, Phelps BR, McClure C, Mofenson LM, Stringer JS2012
21Six-month hemoglobin concentration and its association with subsequent mortality among adults on antiretroviral therapy in Lusaka, ZambiaGiganti MJ, Limbada M, Mwango A, Moyo C, Mulenga LB, Guffey MB, Mulenga PL, Bolton-Moore C, Stringer JS, Chi BH2012
22Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in ZambiaMarseille E, Giganti MJ, Mwango A, Chisembele-Taylor A, Mulenga L, Over M, Kahn JG, Stringer JS2012
23The causal effect of switching to second-line ART in programmes without access to routine viral load monitoringGsponer T, Petersen M, Egger M, Phiri S, Maathuis MH, Boulle A, Musonda P, Tweya H, Peter K, Chi BH, Keiser O; IeDEA Southern Africa2012
24The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatmentSkinner-Adams TS, Butterworth AS, Porter KA, D'Amico R, Sawe F, Shaffer D, Siika A, Hosseinipour MC, Stringer E, Currier JS, Chipato T, Salata R, Lockman S, Eron JJ, Meshnick SR, McCarthy JS2012
25Tuberculosis and HIV control in sub-Saharan African prisons: “thinking outside the prison cell”Reid SE, Topp SM, Turnbull ER, Hatwiinda S, Harris JB, Maggard KR, Roberts ST, Krüüner A, Morse JC, Kapata N, Chisela C, Henostroza G2012
26Variability of growth in children starting antiretroviral treatment in southern AfricaGsponer T, Weigel R, Davies MA, Bolton C, Moultrie H, Vaz P, Rabie H, Technau K, Ndirangu J, Eley B, Garone D, Wellington M, Giddy J, Ehmer J, Egger M, Keiser O; for IeDEA Southern Africa2012
27Evaluation of a Task-Shifting Strategy Involving Peer Educators in HIV Care and Treatment Clinics in Lusaka, Zambia Born LJ, Wamulume C, Neroda KA, Quiterio N, Giganti MJ, Morris M, Bolton-Moore C, Baird S, Sinkamba M, Topp SM, Reid SE.2012
28Nevirapine versus ritonavir-boosted lopinavir for HIV-infected childrenViolari A, Lindsey JC, Hughes MD, Mujuru HA, Barlow-Mosha L, Kamthunzi P, Chi BH, Cotton MF, Moultrie H, Khadse S, Schimana W, Bobat R, Purdue L, Eshleman SH, Abrams EJ, Millar L, Petzold E, Mofenson LM, Jean-Philippe P, Palumbo P2012
29Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studiesWandeler G, Keiser O, Mulenga L, Hoffmann CJ, Wood R, Chaweza T, Brennan A, Prozesky H, Garone D, Giddy J, Chimbetete C, Boulle A, Egger M; IeDEA Southern Africa Collaboration2012